Compliance with Inhaled Corticosteroids and Hospitalization for Asthma (English)
In:
VALUE IN HEALTH
;
2
, 1
;
10
;
1999
-
ISSN:
- Article (Journal) / Print
-
Title:Compliance with Inhaled Corticosteroids and Hospitalization for Asthma
-
Published in:VALUE IN HEALTH ; 2, 1 ; 10
-
Publisher:
- New search for: VALUE IN HEALTH
-
Publication date:1999-01-01
-
Size:10 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 2, Issue 1
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3
-
ISPOR Inaugural European Conference: An OverviewRindress, D. et al. | 1999
- 5
-
Review of Legislation Relating to Promotion of Medicinal Products in the European Union - Are Health Economics Data Covered?| 1999
- 5
-
Identifying Initial Diagnosis in Database Research| 1999
- 6
-
A New Method for Expressing Survival and Life Expectancy in Cancer Patients| 1999
- 6
-
How Do Patients Make Satisfaction Judgments? Answers from Structural Equation Modeling| 1999
- 6
-
Cost-Effectiveness Analysis of High-Dose Chemotherapy with Hematopoietic Rescue as Primary Treatment for Metastatic Breast Cancer| 1999
- 7
-
Practice Patterns of Chemotherapy Usage and Associated Neutropenia and Febrile Neutropenia (FN) in Europe| 1999
- 7
-
An 11-Year, Controlled Study of Healthcare Resource Use and Mortality for Patients with Parkinson's Disease| 1999
- 8
-
Cost-Utility Analysis of Laparoscopic versus Open Surgery for Colonic Disease| 1999
- 8
-
Economic Evaluation of Acamprosate in Maintaining Abstinence in Alcohol-Dependent Patients| 1999
- 8
-
Cross-Cultural Adaptation of the Migraine-Specific Quality of Life Questionnaire (MSQ) in 14 Languages| 1999
- 9
-
DIGEST International Survey: Impact of Upper Gastrointestinal Symptoms on Resource Utilization and Quality of Life| 1999
- 9
-
The Effect of an Open Access Endoscopy Service on Prescribing Costs of Ulcer-Healing Drugs| 1999
- 10
-
Quality of Life of Asthma Patients Relative to Asthma Severity| 1999
- 10
-
Compliance with Inhaled Corticosteroids and Hospitalization for Asthma| 1999
- 10
-
Effectiveness of Oral Ciprofloxacin in the Treatment of Exacerbations of Chronic Airway Diseases| 1999
- 11
-
Is Trimethoprim Resistance an Outcome of Community Antibiotic Prescribing?| 1999
- 11
-
Cross-Cultural Adaptation of the Pediatric Asthma Caregiver Quality of Life Questionnaire (PACQLQ) in 19 Countries| 1999
- 12
-
Ciprofloxacin Is More Successful and Cost-Effective than Trimethoprim/Sulfamethoxazole in the Oral Ambulatory Treatment of Women with Uncomplicated Acute Pyelonephritis| 1999
- 12
-
Preliminary Quality-of-Life Evaluation of the German SAT Trial: Comparison of SF-36, EuroQol, Time Trade-Off Method, and Willingness to Pay Method| 1999
- 12
-
Cost-Effectiveness of Treating High-Risk Individuals, Aged 45-65, with Statins in Germany for Primary and Secondary Prevention of Coronary Heart Disease| 1999
- 13
-
Improved Myocardial Protection during Coronary Bypass Surgery Shortens Hospital Stay and Saves Costs| 1999
- 13
-
Utilization of ACE Inhibitors in Congestive Heart Failure among the Elderly in Quebec| 1999
- 14
-
Road Traffic Accidents Are Associated with Benzodiazepine Use| 1999
- 14
-
Economic Assessment of a Prophylactic Treatment of Recurrence of Ischemic Accidents by Lysine Acetylsalicylate| 1999
- 14
-
Outcome of Acute Myocardial Infarction Patients with Maximal Individual Therapy (Mitra-Study)| 1999
- 15
-
Assessing the Saskatchewan Database for Outcomes Studies of Depression and Its Treatment| 1999
- 15
-
New Benzodiazepine Use Is Associated with an Age-Related Risk of Hospitalization with Fracture and Other Trauma: A Population-Based Study| 1999
- 16
-
Economic Impact of Agitated and Aggressive Behaviors of Elderly Individuals Dwelling in the Community in France: 1. Epidemiology| 1999
- 16
-
Economic Impact of Agitated and Aggressive Behaviors of Elderly Individuals Dwelling in the Community in France: 2. Cost Analysis| 1999
- 16
-
Cost-Utility Analysis of Risperidone in Chronic Schizophrenia| 1999
- 17
-
Patient-Held Instruments for Recording Ambulatory Care Resource Use: Experience in Patients with Diabetic Foot Ulcers| 1999
- 17
-
Self-Monitoring of Blood Glucose in Diabetes: Is It Worth It?| 1999
- 18
-
Assessing the Value of Epoetin- versus Autologous Blood Donation in Orthopedic Surgery: A Feasibility Study of Contingent Valuation| 1999
- 18
-
Antithyroid Drugs or Radioiodine as First-Line Therapy of Graves' Hyperthyroidism in a Country with Strict Regulations for Radiation Protection?| 1999
- 18
-
Measuring the Impact of Diabetic Foot Ulcers on Quality of Life from the Patient's Perspective| 1999
- 19
-
Epoetin- Reduces Postoperative Length of Stay in Patients Undergoing Knee Replacement| 1999
- 20
-
Pharmacoeconomic Efficiency of the Use of Protease Inhibitors for Hospital Inpatients with AIDS| 1999
- 20
-
The Cost-Effectiveness of Itraconazole Solution in the Treatment of Oral Candidiasis in HIV/AIDS Patients: An International Comparison| 1999
- 21
-
Economic Consequences of Monoclonal Antibody 17-1A Adjuvant Therapy of Resected Dukes' C Colorectal Carcinoma in Germany| 1999
- 21
-
Quality of Life in Hodgkin's Disease: Results from the EORTC and GHSG Trials| 1999
- 21
-
Outcome of Monoclonal Antibody 17-1A Adjuvant Therapy of Resected Colon Cancer Dukes' C in Germany: A Subgroup Analysis| 1999
- 22
-
Cost Estimation of Severe Neutropenia in Belgium| 1999
- 22
-
Cost-Effectiveness of Gemcitabine as First-Line Therapy for Patients with Advanced Pancreatic Cancer| 1999
- 22
-
Cost-Minimization in the Use of Colony-Stimulating Factors (CSFs) Based on Clinical Prediction Models (CPMs)| 1999
- 23
-
The Relationship between Profile-Based Quality of Life Scores and EuroQol-5D Scores in Breast Cancer Surgery Patients| 1999
- 23
-
Quality of Life (QoL) of Patients with Low-Grade Non-Hodgkin's Lymphoma (Ig-NHL) Treated with Fludarabine (F) or Cyclophosphamide-Vincristine-Prednisone (CVP)| 1999
- 24
-
Efficacy of Cardiac Rehabilitation Therapy: A Prospective Multicenter Cohort Study| 1999
- 24
-
Adapting Economic Analyses from One Country to Another: Do the WOSCOPS UK Findings Hold in Belgium?| 1999
- 24
-
Cost-Effectiveness of Lipid Modulator Agents| 1999
- 25
-
Potential Cost Savings of the 4 French Infiniti Catheter in Diagnostic Coronary Angiography| 1999
- 25
-
Measuring Disease-Specific Symptom Impact: Development of the Atrial Fibrillation Impact Scale (AFIS)| 1999
- 25
-
The Economic Impact of Hypertension Study from the Pistoia Project| 1999
- 26
-
Cross-Cultural Adaptation of the Seattle Angina Questionnaire (SAQ) in 11 Countries| 1999
- 26
-
Impact of Clinical Sensitivity Analysis in an Evaluation of Primary Prevention of Coronary Heart Disease in Germany| 1999
- 27
-
A Health Economic Evaluation of Hormone Replacement Therapy in Belgium| 1999
- 27
-
Willingness to Pay of Patients with Painful-Irritable Bladder Syndrome| 1999
- 27
-
Comparison of the Epidemiology and Costs Associated with Primary Prevention of Coronary Heart Disease in Five European Countries| 1999
- 28
-
Evaluating Clinical Outcomes of GERD Treatment Options Using Decision Analysis| 1999
- 28
-
The Effects of Ulcer-Healing Drug Coprescription on NSAID-Induced Gastrointestinal Events: A Record Linkage Cohort Study| 1999
- 29
-
Cross-Cultural Adaptation of the Patient Assessment of Constipation-Symptom Questionnaire (PAC-SYM)| 1999
- 29
-
Rate of Gastroprotective Agent Use, Diagnostic Tests, and Hospitalizations among Elderly Patients Who Started Arthrotec, a Fixed Combination of Misoprostol and Diclofenac| 1999
- 30
-
Cost-Effectiveness of Levofloxacin versus Clarithromycin in Patients Evaluable for Clinical Efficacy in the Treatment of Acute Bacterial Sinusitis| 1999
- 30
-
Compliance with American Diabetic Association (ADA) Recommendations in a Type 2 Diabetic Population in an Academic Family Medicine Center| 1999
- 30
-
Cost-Minimization Analysis of Cefamandole and Tobramycin versus Standard Therapy in the Treatment of Patients with Local Appendicular Peritonitis| 1999
- 31
-
Clinical and Economic Characterization of Family Medicine Patients Receiving Antidepressant Drugs| 1999
- 31
-
Annual Direct Costs of Psychotropic Medications for the Treatment of Psychiatric Disorders in India| 1999
- 32
-
The Budget Impact Pharmacotherapy Selection for Major Depressive Disorder: A Multinational Study| 1999
- 32
-
Cost-Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France| 1999
- 33
-
Cost of Alzheimer's Disease Care in the United Kingdom| 1999
- 33
-
Development of a New Disease-Specific Quality of Life Scale for Use in Schizophrenia| 1999
- 33
-
Cross-Cultural Adaptation of the International Index of Erectile Function (IIEF) in 31 Countries| 1999
- 34
-
Results of Disease Management in Headache Treatment| 1999
- 34
-
A UK Primary Care Database (UKPCD)-UK MediPlus as a Readily Available Research Tool for Determining the Incidence and Prevalence of Multiple Sclerosis, Its Treatment, Prescription Costs, and Referrals in UK Practice| 1999
- 34
-
Effect of Risperidone on the Cost of Nursing Home Care for Residents with Behavioral and Psychological Signs and Symptoms| 1999
- 35
-
Quality of Life and Functional Status Measures in Advanced Parkinson's Patients Treated with Pramipexole, Bromocriptine, or Placebo| 1999
- 35
-
A Foundation Study for Cost-Effectiveness Analysis: The Definition of Economic Parameters and Clinical Endpoints in Parkinson's Disease| 1999
- 36
-
Impact of a Cost-Sharing Drug Insurance Plan on Drug Utilization among Individuals Receiving Social Assistance| 1999
- 36
-
Cross-Cultural Adaptation of the Functional Assessment of Multiple Sclerosis (FAMS) Questionnaire in Nine Countries| 1999
- 37
-
Characteristics of Chronic Airway Disease Patients Started on Nebulized Ipratropium Solution| 1999
- 37
-
Cost-Effectiveness of Pramipexole in Parkinson's Disease in Three Countries| 1999
- 37
-
The Effect of Age on Cost-Effectiveness in the Treatment of Moderate Asthma| 1999
- 38
-
Cost-Effectiveness Analysis of a Fixed Combination (Diclofenac + Misoprostol) in the Prevention of Gastropathy in Arthritis Patients in Belgium| 1999
- 38
-
Economic Impact of Smoking in Germany| 1999
- 38
-
Incremental Cost of Disease in Nosocomial Pneumonia from a Hospital's Perspective: A Feasibility Study| 1999
- 39
-
Quality of Life Scores as Predictors of Future Healthcare Resource Use in Patients with Arthritis| 1999
- 39
-
Cost of Illness in Early Rheumatoid Arthritis Stratified for Social Status| 1999
- 40
-
Survival Gains and Degree of Therapeutic Innovation| 1999
- 40
-
Running Cost of Treating a Patient in a General Medical Ward in Sultan Qaboos University Hospital in Oman| 1999
- 40
-
Medication Compliance and Expenditure Impact Associated with Pharmacist's Cognitive Service Interventions| 1999
- 41
-
Linking HRQOLS to Large National Data Sets: EuroQol and HUI Indices| 1999
- 41
-
Using a Surrogate Sample to Derive Patient Preferences for a Cost-Utility Analyses in a Randomized Clinical Trial| 1999
- 42
-
Meta-Analysis of Economic Evaluations: A Methodological Approach and Case Study| 1999
- 42
-
Advanced Sensitivity Analysis by the Integration of Point-Sensitivity and Range-Sensitivity Using Probability Distributions| 1999
- 42
-
Diminishing the Cost of Highly Prescribed Drugs in the Comunidad Valenciana (Spain)| 1999
- 44
-
Monte Carlo Simulation in Healthcare Models| 1999
- 44
-
A Natural History of Alzheimer's Disease: Path-Dependent Evaluation of Clinical and Economic Outcomes Using Decision Database Methodology| 1999
- 45
-
Decision Analysis in Cancer Therapy, A New Way for Evaluation Outcomes with the Analytic Hierarchy Process (AHP)| 1999
- 45
-
The Appropriateness of Common Medical Data Sources: Randomized Trials, Meta-Analyses, Epidemiological and Observational Studies for Pharmacoeconomic Analyses| 1999
- 45
-
Developing Interactive Computer Software for Evaluating the Economic and Clinical Outcomes of Various Treatment Strategies| 1999
- 45
-
The Development and Implementation of Formulary Submission Guidelines for Managed Care in the United States| 1999
- 46
-
Pro and Con: Use of Data from Foreign Pharmacoeconomic Investigations in Russia| 1999
- 46
-
Standardization in the Public Health System of Russia: The First Experience| 1999
- 47
-
The DARTS Diabetes Database: How Can Quality of Life Measurements for Outcomes Research Be Incorporated?| 1999
- 47
-
Standard Procedures for Economic Evaluation: Using a Computer Program for Reporting Economic Evaluations Results (REER)| 1999
- 47
-
The Use of Proxies to Collect Healthcare Resources and Quality of Life Data| 1999
- 48
-
Estimating Drug Effects: From Clinical Trial Results to Actual Practice| 1999
- 48
-
Health Status and Quality of Life Measures in International Clinical Research| 1999
- 48
-
Estimating Population Budget and Health Impacts of New Treatments| 1999
- 49
-
Economic Evaluation of Rehabilitation Programs: The Perspective of Social Old Age Insurance Funds in Germany| 1999
- 49
-
Designing an International Piggyback Study: Providing the Foundation| 1999
- 49
-
Handling Survival Data in Cost-Effectiveness Analysis| 1999
- 50
-
The Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data| 1999
- 50
-
Self-Reported Resource Utilization Data in Pharmacoeconomic Trials: Their Use and Impact on Study Validity| 1999